medspa retatrutide Retatrutide, an investigational triple hormone receptor agonist that shows promise for weight loss in ongoing phase-3 clinical trials, is being sold openly across the internet and prescribed by licensed physicians online and Retatrutide in Chicago: The Next-Generation

Vegan Formula

As of 2026, it was removed from the FDA's Category 2 restriction list and is under active review by the Pharmacy Compounding Advisory Committee, with a scheduled meeting on July 23, 2026, to evaluate its inclusion on the 503A Bulk Drug Substances List

These versions still have the same active ingredients and appetite-reducing effects and should not be used as a workaround to general guidelines

Purchasing through any other channel, including resale listings or third-party supplement sites using the ReadyRx name, should be treated with significant caution

Search volume for the exact query sits at roughly 800 a month, and related searches like "copper uglies" and "copper peptide uglies" pull in hundreds more